Delivery Order SPE2DE24D0013-SPE2D625F2NG6
- Not listed
- The U.S. Defense Department's Medical Supply Chain division awarded a $29,520 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with an ultimate completion date of September 5, 2025. The contract, which carries no set-aside designation, is for molecular diagnostic solutions to be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a for-profit manufacturer of advanced diagnostic systems and test kits, specializes in detecting infectious diseases and clinical...
- The U.S. Defense Department's Medical Supply Chain awarded a $27,235.80 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, with an ultimate completion date of June 13, 2025. This delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions, specializing in advanced GeneXpert diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,437.57 firm fixed-price delivery order to Cepheid Inc. on September 15, 2025, with an ultimate completion date of September 22, 2025. The contract, identified as GXCT/NG-10, carries no set-aside designation and is being performed in Sunnyvale, California, where Cepheid maintains its headquarters. This delivery order represents a continuation of the Department's procurement of molecular diagnostic solutions from Cepheid, a for-profit...
- The U.S. Defense Medical Supply Chain awarded a $1,854 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,930.72 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on May 2, 2025, with an ultimate completion date of May 9, 2025. The contract, designated as XPRSMVP-10, carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid specializes in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $27,235.80 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, designated XPRSMVP-10, was issued on June 4, 2025, with an ultimate completion date of June 11, 2025. The award carries no set-aside designation and represents a continuation of the government's procurement of diagnostic testing solutions from Cepheid, a company...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $31,775.10 by the Defense Department's Medical Supply Chain organization on April 24, 2025. The contract, designated XPRSMVP-10, has an ultimate completion date of May 1, 2025 and carries no set-aside designation. The work will be performed at Cepheid's Sunnyvale facility. This delivery order falls under one of Cepheid's larger Indefinite Delivery...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2NG6Delivery Order
The U.S. Department of Defense Medical Supply Chain awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on June 16, 2025, with an ultimate completion date of June 24, 2025. Cepheid, a for-profit manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. The contract carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This delivery order is consistent with Cepheid's established federal contracting portfolio, which focuses on providing molecular diagnostic testing solutions across multiple defense and civilian healthcare systems. The company maintains significant Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, including a $32.8 million single-award IDV with VA's Veterans Integrated Service Network 6 valued through September 30, 2030, and a $2.5 million IDV with Veterans Integrated Service Network 21. Cepheid's core offerings include GeneXpert diagnostic systems, molecular reagents, test kits, and maintenance services for detecting conditions including COVID-19, influenza, RSV, and various other infectious diseases, positioning the company as a key supplier of diagnostic capabilities within the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/16/25 |